
Med School Research Scientist Timsy Uppal and Engineering post-doctoral researcher Bhaskar Vadlamani testing the SARS-CoV-2 nanosensor.
University of Nevada, Reno engineers and virologists team up for novel approach
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in the past for detecting tuberculosis and colorectal cancer as well as detection of biomarkers for food safety.
Professor Misra, in the University’s College of Engineering Chemical and Materials Department, has been working on nano-sensors for 10 years. He has expertise in detecting a specific biomarker in tuberculosis patients’ breath using a metal functionalized nano sensor.
“I thought that similar technology can be used to detect the SARS-CoV-2 virus, which is a folded protein,” Misra said. “This is Point of Care testing to assess the exposure to COVID-19. We do not need a laboratory setting or trained health care workers to administer the test. Electrochemical biosensors are advantageous for sensing purposes as they are sensitive, accurate and simple.”
The test does not require a blood sample, it is run using a nasal swab or even exhaled breath, which has biomarkers of COVID-19. Misra and his team have successfully demonstrated a simple, inexpensive, rapid and non-invasive diagnostic platform that has the potential to effectively detect the SARS-CoV-2 virus.
The team includes Associate Professor Subhash Verma, virologist, and Research Scientist Timsy Uppal at the University’s School of Medicine, and Misra’s post-doctoral researcher Bhaskar Vadlamani.
“Our role on this project is to provide viral material to be used for detection by the nanomaterial sensor developed by Mano,” Verma said. “Mano contacted me back in April or May and asked whether we can collaborate to develop a test to detect SARS-CoV-2 infection by analyzing patients’ breath. That’s where we came in, to provide biological material and started with providing the surface protein of the virus, which can be used for detecting the presence of the virus.”
Verma, an expert on SARS-CoV-2, synthesized and prepared the antigenic protein of COVID-19 virus in his laboratory, SARS-CoV-2 receptor binding domain protein, for the preliminary testing and determining the sensitivity of our nano sensor. Synthesizing and purification of viral proteins is usual and routine work in a virology laboratory.
“Our lab is a virology laboratory, which works on different viruses, and we have been working on SARS-CoV-2 from the beginning of the outbreak,” he said. “Our genomics and diagnostic group have been sequencing the SARS-CoV-2 from the nasal swabs of COVID-19 patients of the state of Nevada to determine mutational changes in the virus while SARS-CoV-2 circulates in our population.”
The team developed co-metal functionalized nanotubes as a sensing material for electrochemical detection of the protein. They confirmed the biosensor’s potential for clinical application by directly analyzing the RBD of the Spike glycoprotein on the sensor.
The team plans to move to the next step of sensor validation on the actual COVID-19 patients swabs stored in the Viral Transport Medium (VTM) and have applied for funding to develop a specific and inexpensive point-of-care sensor for a rapid detection of COVID-19 virus in saliva or breath of infected individuals.
“A rapid and accurate testing method is critical to establishing a rigorous testing protocol to allow us to continue our operations while maximizing the safety of our students, faculty and staff,” College of Engineering Dean Manos Maragakis said. “I am excited and proud that a research team led by faculty from the College of Engineering in collaboration with faculty from our Medical School are leading such a promising and innovative effort. I am looking forward to the outcome.”
The developed approach also has the potential for diagnosis of other respiratory viral diseases by identifying appropriate metallic elements to functionalize nanotubes.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Covid-19 detection
- Symptoms linger 2 years after COVID-19 for 1 in 6 unvaccinated people
People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new research shows.
- Severe COVID-19 raises alarm for undiagnosed cancer
Severe SARS-CoV-2 infection is associated with a 1.31 higher risk of being diagnosed with cancer following hospital discharge, particularly renal, hematological, colon, and lung cancers, suggesting a ...
- Study Shows High Accuracy in Dogs’ Ability to Sniff Out COVID-19
In a recent study, investigators analyzed the potential to use the highly sensitive sense of smell in dogs to screen for COVID-19. Their conclusion determined that dogs could sniff out SARS-CoV-2 ...
- UT's 'lab-on-a-chip' tech now discerns between COVID-19 & flu
Researchers at the University of Texas at Austin have advanced their portable diagnostic device, the 'lab-on-a-chip', to differentiate between COVID-19 and the flu, paving the way for improved ...
- British company pulls rapid COVID-19 test over Omicron detection concerns
But lab testing showed the diagnostic wasn't able to pick up cases where there was a low level of Omicron present compared to previous coronavirus variants, the company said Monday. The decision comes ...
Go deeper with Google Headlines on:
Covid-19 detection
[google_news title=”” keyword=”Covid-19 detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
SARS-CoV-2 detection
- Study Shows High Accuracy in Dogs’ Ability to Sniff Out COVID-19
In a recent study, investigators analyzed the potential to use the highly sensitive sense of smell in dogs to screen for COVID-19. Their conclusion determined that dogs could sniff out SARS-CoV-2 ...
- Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster
This paper investigates host and viral factors influencing transmission of alpha and delta SARS-CoV-2 variants in the Syrian hamster model and fundamentally increases knowledge regarding transmission ...
- Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
The Panther Fusion SARS-CoV-2/Flu A/B/RSV assay runs on the fully ... their families and communities through early detection and treatment. For more information on Hologic, visit www.hologic.com.
- Study suggests SARS-CoV-2 vaccination in pregnancy induces diverging maternal and infant cord antibody functions
Minimal detection of RBD IgA and IgM was observed ... and antibody potency against SARS-CoV-2 via viral RBD IgG, specifically IgG1, as well as differential antibody glycosylation.
- New method for early visual detection of SARS-CoV-2
It can detect the RBD antigen of the SARS-CoV-2 at an early stage of infection with a visual line of detection (LOD), according to the Ministry of Science & Technology.
Go deeper with Google Headlines on:
SARS-CoV-2 detection
[google_news title=”” keyword=”SARS-CoV-2 detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]